CompletedNot Applicable

Horizontal Anterior Maxillary Ridge Augmentation Using Autogenous Ring Block Grafts Combined With Particulate Xenogeneic Bone Versus Biphasic Beta-tri-calcium Phosphate Sulphate EthOss Graft: A Clinical Study

Egypt40 participantsStarted 2023-01-05

Plain-language summary

. Group A, received ABG cylinders obtained from the chin and organic bovine bone mineral particles (Bio-Oss xenograft) along with an absorbable collagen membrane. ABG cylinders from the chin and biphasic alloplastic (EthOss) grafting material made of CS (35%) and TCP (65%) were given to Group B. CBCT scans were conducted before bone augmentation surgery, one week and 6 months postoperatively

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults ≥18 years requiring implant-supported restoration in the anterior maxilla Horizontal alveolar bone deficiency \<4 mm (Cawood \& Howell Class III-IV) Satisfactory oral hygiene No previous bone augmentation at study site Exclusion Criteria: * Uncontrolled systemic diseases History of head/neck irradiation or immunosuppression Oral lesions (e.g., lichen planus) Ongoing or recent IV bisphosphonate therapy Untreated periodontitis or poor oral hygiene Parafunctional habits, pregnancy, psychiatric disorders Recent tobacco use

What they're measuring

Change in horizontal alveolar ridge width

Timeframe: Baseline, 1 week, and 6 months post-surgery

Trial details

NCT IDNCT07212985

SponsorAl-Azhar University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-05

View on ClinicalTrials.gov More Implant Dentistry trials